Moreover, TNFRSF12A expression was up-regulated as the glioma grade increased (Figure 7J). The expression of TNFRSF12A in GBM patients was highest among all glioma subtypes (Figure 7K). This evidence concerns the gene TNFRSF12A and central nervous system cancer.